CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later) 		 
     
 
 
 
Mologen AG Company Snapshot
Business Description:
Mologen AG operates in the Pharmaceutical preparations sector. MOLOGEN AG is a biotechnology company researching and developing deoxyribonucleic acid (DNA)-based drugs for diseases that require a high degree of medical treatment. The Company's activities concentrate on creating new and improving existing immunological drugs and therapies to combat cancer and developing vaccines for the prevention and treatment of serious infectious diseases in humans, as well as animals. Two core areas of the Company's operations are the treatment of cancer and infectious diseases. The Company developed and patented the DNA-based platform technologies MIDGE as well as dSLIM which provide the basis for prophylactic and therapeutic applications for treatment of diseases, represented by a range of cancer therapy solutions. In addition, the Company offers DNA vaccine against leishmaniasis. In our complete report available for purchase the company is compared to: Reneuron Group PLC, Futura Medical PLC and Biofrontera AG.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Mologen AG
  Stock Performance Chart for Mologen AG
 
  Stock Data: Recent Stock Performance:
  Current Price (2/3/2012): 7.99
(Figures in Euro)
1 Week 3.8%   13 Weeks 11.1%  
4 Weeks 13.2%   52 Weeks -6.2%  
 
Mologen AG Key Data:
  Ticker: MGN Country: GERMANY
  Exchanges: FRA OTH Major Industry: Miscellaneous
    Sub Industry: Medical Services
  2010 Sales 89,000
(Year Ending Jan 2011).		 Employees: 44
  Currency: Euro Market Cap: 99,549,607
  Fiscal Yr Ends: December Shares Outstanding: 12,459,275
  Share Type: Stammaktie Closely Held Shares: 4,261,072
 
 
Featured Products and Services
  
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.